The Department of Cardiovascular & Metabolic Sciences is home to scientists with broad expertise in cardiovascular and related systems as well as cellular metabolism related to diabetes, cancer and heart disease.
More About UsThe Luse lab studies molecular events that drive promoter recognition and transcription of genes in chromosomes.
Learn MoreThe Perez lab discerns the roles of α1-adrenergic receptor subtypes in physiological and pathophysiological states.
Learn MoreThe Reizes lab studies ovarian cancer and triple negative breast cancer, focusing on novel therapeutic development.
Learn MorePlatelet protein GPVI was revealed as a biomarker for abdominal aortic aneurysm screening (AAA).
Study shows beta-2 adrenergic receptors can be regulated from a new site which allows healthy signals through, minimizing harmful side effects of beta-blocker medications.
The pathway serves as a strong biomarker for predicting risk for developing heart failure and could be a target for therapeutics.
Exciting investigation and groundbreaking discovery happens every day at Cleveland Clinic. Join our team of expert researchers at the Department of Cardiovascular & Metabolic Sciences.
View Careers